相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TGF-beta-RI Kinase Inhibitor SD-208 Reduces the Development and Progression of Melanoma Bone Metastases
Khalid S. Mohammad et al.
CANCER RESEARCH (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Metastasis and bone loss: Advancing treatment and prevention
Robert E. Coleman et al.
CANCER TREATMENT REVIEWS (2010)
Effects of transforming growth factor β on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts
S.E. Harris et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Inhibition of TGF-β Signaling by 1D11 Antibody Treatment Increases Bone Mass and Quality In Vivo
James R. Edwards et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
Alison T. Stopeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Targeting the Transforming Growth Factor-β pathway inhibits human basal-like breast cancer metastasis
Vidya Ganapathy et al.
MOLECULAR CANCER (2010)
Pharmacologic Inhibition of the TGF-β Type I Receptor Kinase Has Anabolic and Anti-Catabolic Effects on Bone
Khalid S. Mohammad et al.
PLOS ONE (2009)
Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment
Lauren K. Dunn et al.
PLOS ONE (2009)
TGF-β signalling-related markers in cancer patients with bone metastasis
Jose Baselga et al.
BIOMARKERS (2008)
An anti-transforming growth factor β antibody suppresses metastasis via cooperative effects on multiple cell compartments
Jeong-Seok Nam et al.
CANCER RESEARCH (2008)
PTH-related peptide (PTHrP) in hypercalcemia
Gregory R. Mundy et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells
Julie A. Sterling et al.
CANCER RESEARCH (2006)
TGFβ:: the molecular Jekyll and Hyde of cancer
Brian Bierie et al.
NATURE REVIEWS CANCER (2006)
Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-β type I receptor kinase inhibitor
Abhik Bandyopadhyay et al.
CANCER RESEARCH (2006)
RANKL-RANK signaling in osteoclastogenesis and bone disease
T Wada et al.
TRENDS IN MOLECULAR MEDICINE (2006)
TGF-β regulates the mechanical properties and composition of bone matrix
G Balooch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Anti-transforming growth factor antibody at low but not high doses limits cyclosporine-mediated nephrotoxicity without altering rat cardiac allograft survival - Potential of therapeutic applications
AK Khanna et al.
CIRCULATION (2004)
Development of TGF-β signalling inhibitors for cancer therapy
JM Yingling et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma - A randomized, double-blind, multicenter, comparative trial
LS Rosen et al.
CANCER (2003)
Therapeutic role of TGF-β-neutralizing antibody in mouse cyclosporin a nephropathy:: Morphologic improvement associated with functional preservation
H Ling et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
The effect of the bisphosphonate ibandronate on breast cancer metastasis to visceral organs
T Michigami et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
Metastasis to bone: Causes, consequences and therapeutic opportunities
GR Mundy
NATURE REVIEWS CANCER (2002)
Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects
YA Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Reaching a genetic and molecular understanding of skeletal development
G Karsenty et al.
DEVELOPMENTAL CELL (2002)
The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis
AJ Borton et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
TGF-β-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation
T Alliston et al.
EMBO JOURNAL (2001)
TGF-β/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage
X Yang et al.
JOURNAL OF CELL BIOLOGY (2001)
分享论文
